Suppr超能文献

机器人手术:一种用于乳房手术和重建的新方法。

Robotic Surgery: A Novel Approach for Breast Surgery and Reconstruction.

作者信息

Donnely Edward, Griffin Michelle F, Butler Peter E

机构信息

Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, UK.

出版信息

Plast Reconstr Surg Glob Open. 2020 Jan 29;8(1):e2578. doi: 10.1097/GOX.0000000000002578. eCollection 2020 Jan.

Abstract

UNLABELLED

Breast cancer is the most prevalent cancer and second leading cause of cancer-related deaths in both the US and UK female population, a prominent cause of morbidity and cost to both health services. All surgically fit patients are offered breast reconstruction following the initial surgery, and this is traditionally an open approach: either implant-based or an autologous tissue flap. Both lead to scarring that is difficult to conceal. This paper aims to evaluate the novel minimally invasive technique of robotic-assisted surgery.

METHODS

A systematic review was conducted using Medline (OvidSP) and Embase (OvidSP) to evaluate the current application of robotic-assisted surgery in breast surgery and reconstruction.

RESULTS

Twenty-one articles were identified and discussed, composing of level 4 and 5 evidence comparing different surgeons' experiences, techniques, and outcomes. To date, the robotic system has been utilized to harvest the latissimus dorsi muscle for use as a tissue flap (total harvest time of 92 minutes), to perform nipple-sparing mastectomy with immediate breast reconstruction (total operation time 85 minutes) and lately to harvest a deep inferior epigastric perforator flap via an intraabdominal approach.

CONCLUSIONS

Robotic-assisted surgery can successfully and reproducibly perform a nipple-sparing mastectomy with breast reconstruction. It can minimize the size of scarring and is superior to the laparoscopic technique, with improved 3-dimensional visualization, dexterity, and range of motion able to guide around the curvature of the breast. The main limiting factors are the lack of the US Food and Drug Administration approval, cost of the robot, and specialized skills required.

摘要

未标注

乳腺癌是美国和英国女性群体中最常见的癌症,也是癌症相关死亡的第二大主要原因,是导致发病和给医疗服务带来成本的一个突出原因。所有适合手术的患者在初次手术后都可接受乳房重建,传统上这是一种开放式手术:要么是植入式,要么是自体组织皮瓣。这两种方式都会导致难以隐藏的疤痕。本文旨在评估机器人辅助手术这种新型微创技术。

方法

使用Medline(OvidSP)和Embase(OvidSP)进行系统评价,以评估机器人辅助手术在乳房手术和重建中的当前应用。

结果

共识别并讨论了21篇文章,这些文章构成了比较不同外科医生经验、技术和结果的4级和5级证据。迄今为止,机器人系统已被用于获取背阔肌用作组织皮瓣(总获取时间92分钟),进行保留乳头的乳房切除术并立即进行乳房重建(总手术时间85分钟),最近还通过腹腔内入路获取腹壁下深动脉穿支皮瓣。

结论

机器人辅助手术能够成功且可重复地进行保留乳头的乳房切除术并进行乳房重建。它可以将疤痕尺寸最小化,并且优于腹腔镜技术,具有改进的三维可视化、灵活性和能够围绕乳房曲率引导的活动范围。主要限制因素是缺乏美国食品药品监督管理局的批准、机器人的成本以及所需的专业技能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e2c/7015621/da14a5ebfe99/gox-8-e2578-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验